Georgia's Online Cancer Information Center

Graft Versus Host Disease Clinical Trials in Georgia

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Cancer Type = Graft Versus Host Disease
Cancer Type = Graft Versus Host Disease
There are currently 2 active Graft Versus Host Disease clinical trials in Georgia.
1.
Expanded Access Program for Axatilimab in Chronic Graft Versus Host Disease (GVHD)
Cancer Type
Graft Versus Host Disease
NCT ID
NCT05544032
Protocol IDs
INCA 34176-MA-GD-301
Treatment Sites (1)
2.
NCORP Trial
Phase II Trial of Belumosudil and Rituximab for the Primary Treatment of Extensive Chronic Graft-versus-host Disease
Cancer Type
Graft Versus Host Disease
NCT ID
NCT06046248
Protocol IDs
NSH 1385
Treatment Sites (1)